skip navigation

S M L Text size
Home » Resources » Clinical Studies » Trial of Bifocals in Myopic Children With Esophoria, A

NEI Clinical Studies

Archived Page

The information on this page is archived and provided for reference purposes only. It was current when it was produced, but may now be out-of-date. Persons having difficulty accessing this information may contact kcl@nei.nih.gov for assistance. For reliable, current information on this and other topics, we recommend that you visit the National Eye Institute website index.

Trial of Bifocals in Myopic Children With Esophoria, A

Purpose | Background | Description | Patient Eligibility | Recruitment Status | Current Status | Results | Publications | Resource Centers | NEI Representative

Purpose

To test the hypothesis that correction with bifocal spectacle lenses rather than single-vision lenses will slow the progression of myopia in children with near-point esophoria. The primary outcome variable is cycloplegic refraction as measured with an automated refractor. Axial length is measured with ultrasound in order to test the corollary hypothesis that use of bifocals will slow ocular growth in these myopic children. We will also examine the amount of close work performed by subjects and the degree of parental myopia as factors that may influence myopia progression.

Background

About 25 percent of all persons in the United States are myopic. The most common form of myopia is childhood myopia, which begins after age 6 and progresses rapidly until age 16. Myopia progression results from excessive growth of the eye, primarily by enlargement of the vitreous chamber. Excessive elongation of the eye is a major risk factor for retinal detachment.

Previous prospective studies failed to show that use of bifocals was effective in slowing myopia progression. However, these studies did not separate subjects by near-point phoria before randomization. Retrospective studies by David Goss indicated that bifocals slowed myopia progression by almost 50 percent in children with near-point esophoria but had no effect on children with exophoria.

A small, prospective pilot study, completed by the investigators of this trial, also supported the hypothesis that bifocals slow myopia progression in children with near-point esophoria. Thirty-two myopic children, all of whom showed near-point esophoria, were enrolled in this 18-month study. Twenty-eight children completed the study, with 14 randomized into bifocals and 14 into single-vision lenses. Cycloplegic automated refraction was performed every 6 months. Over the course of the whole study, there was a small, statistically insignificant difference in the rates of myopia progression: 0.57 diopters per year (D/yr) (S.E. = 0.11) for those in single-vision lenses compared with 0.36 D/yr (S.E. = 0.12) for those in bifocals (p = 0.26).

However, significant seasonal effects in myopia progression were demonstrated, and the results also suggested that the beneficial effects of bifocals may take several months to develop. During the first 6 months, which included most of the school year, myopia progression was rapid in both the bifocal group (0.61 D/yr) and the single-vision group (0.68 D/yr). During the second 6 months, which included all of the summer vacation, myopia progression was slow in both groups, 0.32 and 0.26 D/yr for bifocal wearers and single-vision wearers, respectively. During the last 6 months, i.e., the second school year, myopia progressed slowly in the bifocal wearers (0.37 D/yr) but rapidly (0.80 D/yr) in single-vision wearers. A repeated-measure analysis of variance demonstrated a significant seasonal effect (p < 0.002) and a significant interaction between season and type of correction (p < 0.043).

The apparent effectiveness of bifocals in children with near-point esophoria and the lack of effectiveness in other children may be explained by a greater lag of accommodation in children with esophoria. This lag might cause a slightly blurred retinal image that the bifocal may sharpen. Other mechanisms might also be involved.

Description

Eighty or more myopic children, all with near-point esophoria as measured at baseline with von Graefe prisms through a current myopic correction placed in a phoropter, will be randomly assigned to wear either single-vision spectacle lenses or lenses with +1.50 D add in a flat-top 28-mm segment. Subjects will visit one of two sites, either a private optometry practice in Tulsa or the optometry clinic at Northeastern State University, every 6 months. Data collected at each visit will include automated refraction after cycloplegia with 1 percent tropicamide, biometry with A-scan, and estimates of the amount of study and other close work by means of questionnaires administered to the subjects and their parents. We will also obtain measures of the degree of myopia in the biological parents. The myopic correction will be changed if the spherical component of the refraction in either eye has changed by 0.5 diopter or more or if any change in cylinder power or axis improves vision in either eye by three letters or more. The study will continue for 30 months and will include six visits by each subject.

Patient Eligibility

Boys must have been between 6 and 12 years of age; girls between 6 and 11 years of age. All children must have had at least 0.5 diopters of myopia in both eyes, near-point esophoria, at least 20/25 acuity in each eye, and 40 seconds of stereopsis and must have been free of ocular disease or systemic disease that may have altered refraction. All subjects were willing to wear bifocal spectacle lenses for 30 months.

Patient Recruitment Status

Recruitment began in summer 1996 and was completed in fall 1996.

Current Status of Study

Completed.

Results

Eighty-two myopic children, all showing esophoria at 40 cm, were randomized to single-vision glasses (n=40) or to bifocals with a +1.50 add (n=42) and were followed for 30 months. Refraction was measured by an automated refractor after cycloplegia with 1-percent tropicamide. Myopia progression was defined as the difference between the spherical equivalent at baseline and that at the 30-month examination, averaged over both eyes. Change in vitreous chamber depth was assessed with ultrasonography.

Follow-up was incomplete for six children in the bifocal group and one child in the single-vision group. Among the children completing the 30 months of follow up, myopia progression averaged 0.99 D for bifocals and 1.24 D for single vision (unadjusted p=0.106, adjusted for age p=0.046). The distribution of myopia progression in the treatment group was non-normal with five children progressing very rapidly. The median progression rate for bifocal children was 0.92 D and 1.24 D for those in single vision (p=0.047). The treatment effect on growth in vitreous chamber depth was similar (p=0.046).

Use of bifocals, instead of single-vision glasses, by children with near-point esophoria appeared to slow myopia progression to a slight degree.

Publications

Fulk GW, Cyert LA, Parker DE: A randomized trial of the effect of single-vision vs bifocal lenses on myopia progression in children with esophoria. Optom Vis Sci 77: 395-401, 2000.

Fulk GW, Cyert LA, Parker DE: A 3-year clinical trial of bifocals to slow myopia progression in children with near-point esophoria: Baseline characteristics. Invest Ophthalmol Vis Sci 38(4): S1158, 1997.

Fulk GW, Cyert LA: Can bifocals slow myopia progression?. J Am Optom Assoc 67(12): 749-54, 1996.

Resource Centers

Chairman's Office
George W. Fulk, Ph.D., O.D.
Lynn A. Cyert, Ph.D., O.D.
College of Optometry
Northeastern State University
Tahlequah, OK 74464
Telephone: (918) 456-5511 x4019
E-mail: Fulk@Cherokee.nsuok.edu
http://arapaho.nsuok.edu/~optometry/optometry1.htm

Data Coordinating Center
Pavel Bossine, Ph.D.
College of Business
Northeastern State University
Tahlequah, OK 74464
Telephone: (918) 456-5511 x3095
E-mail: Bosin@Cherokee.nsuok.edu

NEI Representative

Donald Everett, M.A.
Clinical Trials Branch
National Eye Institute
6120 Executive Boulevard MSC 7164
Bethesda, MD 20892-7164
Telephone: (301) 496-5983
Fax: (301) 402-0528

Last Updated: 12/18/01



Department of Health and Human Services NIH, the National Institutes of Health USA.gov